Loading clinical trials...

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution. | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 3NCT00204165

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Entero...

Lead sponsor: University of Oslo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment40

Start dateNov 2004

Last updatedSep 11, 2006

Condition

Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

Locations shown

Ulleval Universitets sykehus

Kirkeveien 166, Oslo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 11, 2006Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions